These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 22209677)

  • 21. Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture.
    Cooper ME; El-Osta A; Allen TJ; Watson AMD; Thomas MC; Jandeleit-Dahm KAM
    Diabetes; 2018 May; 67(5):785-790. PubMed ID: 29678824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Aiello LP;
    Diabetes Care; 2014; 37(1):17-23. PubMed ID: 24356593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications.
    Kang Q; Yang C
    Redox Biol; 2020 Oct; 37():101799. PubMed ID: 33248932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes.
    Ahmed N; Babaei-Jadidi R; Howell SK; Thornalley PJ; Beisswenger PJ
    Diabetes Care; 2005 Oct; 28(10):2465-71. PubMed ID: 16186281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
    Monnier VM; Sell DR; Strauch C; Sun W; Lachin JM; Cleary PA; Genuth S;
    J Diabetes Complications; 2013; 27(2):141-9. PubMed ID: 23153673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of hyperglycemia mediated increased advanced glycation and erythrocyte antioxidant enzyme activity in different stages of diabetic retinopathy.
    Choudhuri S; Dutta D; Chowdhury IH; Mitra B; Sen A; Mandal LK; Mukhopadhyay S; Bhattacharya B
    Diabetes Res Clin Pract; 2013 Jun; 100(3):376-84. PubMed ID: 23602454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress in diabetic patients with retinopathy.
    Kundu D; Mandal T; Nandi M; Osta M; Bandyopadhyay U; Ray D
    Ann Afr Med; 2014; 13(1):41-6. PubMed ID: 24521578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end products and diabetic complications: a general overview.
    Peppa M; Vlassara H
    Hormones (Athens); 2005; 4(1):28-37. PubMed ID: 16574629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical review 2: The "metabolic memory": is more than just tight glucose control necessary to prevent diabetic complications?
    Ceriello A; Ihnat MA; Thorpe JE
    J Clin Endocrinol Metab; 2009 Feb; 94(2):410-5. PubMed ID: 19066300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
    Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic retinopathy--biomolecules and multiple pathophysiology.
    Ahsan H
    Diabetes Metab Syndr; 2015; 9(1):51-4. PubMed ID: 25450817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic memory: Evolving concepts.
    Misra A; Bloomgarden Z
    J Diabetes; 2018 Mar; 10(3):186-187. PubMed ID: 29091343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic retinopathy and atherosclerosis: is there a link?
    Ellis TP; Choudhury RH; Kaul K; Chopra M; Kohner EM; Tarr JM; Chibber R
    Curr Diabetes Rev; 2013 Mar; 9(2):146-60. PubMed ID: 23094754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia and microvascular and macrovascular disease in diabetes.
    Klein R
    Diabetes Care; 1995 Feb; 18(2):258-68. PubMed ID: 7729308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early risk stratification in pediatric type 1 diabetes.
    Broe R
    Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel approach of proteomics to study the mechanism of action of grape seed proanthocyanidin extracts on diabetic retinopathy in rats.
    Li M; Ma YB; Gao HQ; Li BY; Cheng M; Xu L; Li XL; Li XH
    Chin Med J (Engl); 2008 Dec; 121(24):2544-52. PubMed ID: 19187593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycated proteins in diabetes.
    Beisswenger PJ; Szwergold BS; Yeo KT
    Clin Lab Med; 2001 Mar; 21(1):53-78, vi. PubMed ID: 11321937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.